Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

APO Medical Opportunities

+ Add to Watchlist

WZFA:GR

126.2500 EUR 1.8100 1.45%

As of 10:40:51 ET on 03/27/2015.

Snapshot for APO Medical Opportunities (WZFA)

Open: 124.6700 High - Low: 126.7700 - 124.2390 Primary Exchange: Frankfurt
Volume: 80 52-Week Range: 96.8300 - 131.4300 Beta vs DAX: 0.6014

ETF Chart for WZFA

No chart data available.
  • WZFA:GR 124.2390
  • 1D
  • 1M
  • 1Y
124.4400
Interactive WZFA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for WZFA

APO Medical Opportunities is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equities of companies from the health care sector.

Inception Date: Telephone: 352-260248-1 Tel
Managers: KAI BRUENING / HARALD SCHWARZ
Web Site: www.ipconcept.lu

Fundamentals for WZFA

NAV (on 2015-03-26) 126.3200
Assets (M) (on 2015-03-27) 188.3357
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -1.49
Average 52-Week % Premium -0.7042
Fund Leveraged N

Dividends for WZFA

Dividend Type Omitted
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -%

Performance for WZFA

1-Month +1.56% 1-Year +23.13%
3-Month +11.76% 3-Year +22.24%
Year To Date +10.28% 5-Year +15.73%
Expense Ratio -

Top Fund Holdings for WZFA

Filing Date: 02/28/2015
Name Position Value % of Total
Novartis AG 67,083 5,965,511 3.190%
Bayer AG 34,384 4,525,560 2.420%
Abbott Laboratories 95,904 4,058,043 2.170%
GlaxoSmithKline PLC 186,477 3,964,540 2.120%
Amgen Inc 28,008 3,945,839 2.110%
BioMarin Pharmaceutical Inc 41,257 3,945,839 2.110%
Pfizer Inc 127,491 3,908,438 2.090%
Edwards Lifesciences Corp 27,385 3,253,915 1.740%
H Lundbeck A/S 176,970 3,141,711 1.680%
Sanofi 35,610 3,123,010 1.670%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil